GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Innova Captab Ltd (BOM:544067) » Definitions » Return-on-Tangible-Asset

Innova Captab (BOM:544067) Return-on-Tangible-Asset : 7.57% (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Innova Captab Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Innova Captab's annualized Net Income for the quarter that ended in Mar. 2025 was ₹1,183 Mil. Innova Captab's average total tangible assets for the quarter that ended in Mar. 2025 was ₹15,630 Mil. Therefore, Innova Captab's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 was 7.57%.

The historical rank and industry rank for Innova Captab's Return-on-Tangible-Asset or its related term are showing as below:

BOM:544067' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 8.95   Med: 10.91   Max: 14.42
Current: 8.98

During the past 7 years, Innova Captab's highest Return-on-Tangible-Asset was 14.42%. The lowest was 8.95%. And the median was 10.91%.

BOM:544067's Return-on-Tangible-Asset is ranked better than
77.61% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 2.68 vs BOM:544067: 8.98

Innova Captab Return-on-Tangible-Asset Historical Data

The historical data trend for Innova Captab's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innova Captab Return-on-Tangible-Asset Chart

Innova Captab Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Return-on-Tangible-Asset
Get a 7-Day Free Trial 9.43 13.79 10.91 9.48 8.95

Innova Captab Quarterly Data
Mar19 Mar20 Mar21 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.81 9.05 9.88 9.65 7.57

Competitive Comparison of Innova Captab's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Innova Captab's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innova Captab's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Innova Captab's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Innova Captab's Return-on-Tangible-Asset falls into.


;
;

Innova Captab Return-on-Tangible-Asset Calculation

Innova Captab's annualized Return-on-Tangible-Asset for the fiscal year that ended in Mar. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=1282.58/( (13032.91+15629.69)/ 2 )
=1282.58/14331.3
=8.95 %

Innova Captab's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=1182.92/( (0+15629.69)/ 1 )
=1182.92/15629.69
=7.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2025) net income data.


Innova Captab  (BOM:544067) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Innova Captab Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Innova Captab's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Innova Captab Business Description

Traded in Other Exchanges
Address
SCO No. 301, Sector 9, Second Floor, Panchkula, HR, IND, 134109
Innova Captab Ltd is an integrated pharmaceutical company in India and is engaged in research and development, manufacturing, drug distribution, and marketing and exports. Company business includes (i) a contract development and manufacturing organization ("CDMO") business providing manufacturing services to Indian pharmaceutical companies, (ii) a domestic branded generics business, and (iii) an international branded generics business.

Innova Captab Headlines

No Headlines